Translation and Validation of the French mPCOSQ (mPCOSQ-F).

Recruiting now

Conditions studied: Polycystic Ovary Syndrome Health-related Quality of Life

In brief

This study is a prospective, observational, bicentric study, evaluating the validity and reliability of a French version of the mPCOSQ questionnaire (mPCOSQ-F), used to assess health-related quality of life (HRQOL) in women with polycystic ovary syndrome. The first stage of the study consisted in translating the questionnaire from English to French. Patients agreeing to take part in the study will complete the mPCOSQ-F and the SF-36 (generic HRQOL questionnaire). After 1 to 2 weeks, patients will receive the mPCOSQ-F and complete it again.

Key facts

Study ID

NCT07016035

Run by

CHU de Reims

People needed

350

Starts

2025-05-12

Expected to finish

2027-05-12

Last updated by the study team

2025-08-07

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women aged 18 to 45
• Fluent in french
• Having a diagnosis of PCOS according to the international recommendations published in 2023
• Willing to participate in the study
• Affiliated to the french social security system

You may not qualify if…

• Diagnosis of adrenal hyperplasia, androgen-producing tumor, Cushing's syndrome, or thyroid disorder
• Pregnancy or breast-feeding
• Under legal protection

Where it is running

• Damien JOLLY — Reims, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.